These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Lysosomal acid lipase and atherosclerosis. Du H; Grabowski GA Curr Opin Lipidol; 2004 Oct; 15(5):539-44. PubMed ID: 15361789 [TBL] [Abstract][Full Text] [Related]
24. Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in mice. Du H; Heur M; Witte DP; Ameis D; Grabowski GA Hum Gene Ther; 2002 Jul; 13(11):1361-72. PubMed ID: 12162818 [TBL] [Abstract][Full Text] [Related]
25. Cholesteryl ester storage disease: a most unusual manifestation of deficiency of two lysosomal enzyme activities. Fredrickson DS; Sloan HR; Ferrans VJ; Demosky SJ Trans Assoc Am Physicians; 1972; 85():109-19. PubMed ID: 4660005 [No Abstract] [Full Text] [Related]
26. Drug-induced intralysosomal storage of sulfated glycosaminoglycans (GAGs): a methodical pitfall occurring with acridine derivatives. Lüllmann-Rauch R Exp Toxicol Pathol; 1994 Oct; 46(4-5):315-22. PubMed ID: 7894242 [TBL] [Abstract][Full Text] [Related]
27. Reduction of atherosclerotic plaques by lysosomal acid lipase supplementation. Du H; Schiavi S; Wan N; Levine M; Witte DP; Grabowski GA Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):147-54. PubMed ID: 14615393 [TBL] [Abstract][Full Text] [Related]
28. A unique familial leukodystrophy with adult onset dementia and abnormal glycolipid storage: a new lysosomal disease? Simon DK; Rodriguez ML; Frosch MP; Quackenbush EJ; Feske SK; Natowicz MR J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):251-4. PubMed ID: 9703182 [TBL] [Abstract][Full Text] [Related]
29. Homozygous TBC1 domain-containing kinase (TBCK) mutation causes a novel lysosomal storage disease - a new type of neuronal ceroid lipofuscinosis (CLN15)? Beck-Wödl S; Harzer K; Sturm M; Buchert R; Rieß O; Mennel HD; Latta E; Pagenstecher A; Keber U Acta Neuropathol Commun; 2018 Dec; 6(1):145. PubMed ID: 30591081 [TBL] [Abstract][Full Text] [Related]
30. Caenorhabditis elegans as a model for lysosomal storage disorders. de Voer G; Peters D; Taschner PE Biochim Biophys Acta; 2008; 1782(7-8):433-46. PubMed ID: 18501720 [TBL] [Abstract][Full Text] [Related]
31. The lesions of an ovine lysosomal storage disease. Initial characterization. Murnane RD; Prieur DJ; Ahern-Rindell AJ; Parish SM; Collier LL Am J Pathol; 1989 Feb; 134(2):263-70. PubMed ID: 2916646 [TBL] [Abstract][Full Text] [Related]
32. Characterization of lpd (lipid defect): a novel mutation on mouse chromosome 16 associated with a defect in triglyceride metabolism. Wen XY; Bryce DM; Breitman ML Hum Mol Genet; 1998 Apr; 7(4):743-50. PubMed ID: 9499429 [TBL] [Abstract][Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]